U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
4374143741Fitness, Aging, and Stress StudyRecruitingNo Results AvailableAging|Stress|Disease RiskBehavioral: Aerobic Training Interventionhttps://ClinicalTrials.gov/show/NCT01993082
4374243742Yoga Training for Returning Veterans With HeadacheRecruitingNo Results AvailablePost Traumatic Headache|Chronic Daily HeadacheBehavioral: Iyengar-based Yoga Traininghttps://ClinicalTrials.gov/show/NCT01993069
4374343743The Influence of 11+ on Injury Incidence and FMS-Score in Veteran Soccer PlayersCompletedNo Results AvailableInjuryBehavioral: "FIFA 11+"|Behavioral: no "FIFA 11+"https://ClinicalTrials.gov/show/NCT01993056
4374443744Laser and Bevacizumab Treatment for Retinopathy of PrematurityRecruitingNo Results AvailableFocus of the Study is to Evaluate the Efficacy and Safety of Bevacizumab for the Treatment of ROP.https://ClinicalTrials.gov/show/NCT01993043
4374543745Evaluation of HQ® Matrix Medical Wound Dressing for Healing of Donor Site WoundsCompletedHas ResultsDonor Site WoundDevice: HQ® Matrix Medical Wound Dressing|Device: Sidaiyi® wound dressinghttps://ClinicalTrials.gov/show/NCT01993030
4374643746Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost OutcomesRecruitingNo Results AvailableAcute Coronary Syndrome|Depressive SymptomsOther: Cognitive Behavioral Therapy (CBT)|Drug: Antidepressant Medication|Other: Standard Care|Other: Depressive symptom screenerhttps://ClinicalTrials.gov/show/NCT01993017
4374743747Immune Regulation in Multiple Sclerosis: The Effect of Glatiramer Acetate on MicroRNA Expression in Antigen-Presenting CellsActive, not recruitingNo Results AvailableMultiple Sclerosishttps://ClinicalTrials.gov/show/NCT01993004
4374843748Transcranial Stimulation for Upper Limb Training of Individuals With Sequelae From Intracranial HemorrhageActive, not recruitingNo Results AvailableCerebrovascular DisordersDevice: Transcranial direct current stimulationhttps://ClinicalTrials.gov/show/NCT01992991
4374943749Radiofrequency-assisted Hepatectomy on the Outcomes of HCC Patients With CirrhosisRecruitingNo Results AvailableHepatocellular Carcinoma|CirrhosisProcedure: Radiofrequency-assisted Hepatectomy|Procedure: Conventional Hepatectomyhttps://ClinicalTrials.gov/show/NCT01992978
4375043750Effect of Real-time Continuous Glucose Monitoring on Glucose Control and Outcomes of Critically Ill PatientsRecruitingNo Results AvailableHyperglycemiaOther: Different methods of blood glucose monitoring between groupshttps://ClinicalTrials.gov/show/NCT01992965
4375143751Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast CancerRecruitingNo Results AvailableEstrogen Receptor Positive Breast CancerDrug: AZD5363|Drug: Placebo|Drug: Fulvestranthttps://ClinicalTrials.gov/show/NCT01992952
4375243752The Effect of Heat on Blood and Oxygen Flow Readings Part 2RecruitingNo Results AvailableHealthy|Peripheral Vascular Disease|VasoconstrictionOther: Specialized pulse oximetry probe with external heat pack|Other: Standard of Care Pulse Oximetry Probehttps://ClinicalTrials.gov/show/NCT01992939
4375343753Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid TrialCompletedNo Results AvailableChronic Kidney Disease|End Stage Renal DiseaseBehavioral: interactive educational interventionhttps://ClinicalTrials.gov/show/NCT01992926
4375443754Building Employment Skills Through Therapy for VeteransRecruitingNo Results AvailableSchizophrenia|Schizoaffective DisorderBehavioral: integrated Cognitive Behavioral Therapy|Behavioral: Psychoeducation|Behavioral: Computerized cognitive remediationhttps://ClinicalTrials.gov/show/NCT01992913
4375543755A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum MalariaCompletedNo Results AvailablePlasmodium Falciparum Malaria.Drug: Eurartesim dispersible oral tablet|Drug: eurartesim film coated tablethttps://ClinicalTrials.gov/show/NCT01992900
4375643756Pre-ART Retention in Care in TanzaniaActive, not recruitingNo Results AvailableHIV (Human Immunodeficiency Virus)|AIDS (Acquired Immunodeficiency Syndrome)https://ClinicalTrials.gov/show/NCT01992887
4375743757Relative Bioavailability of Pimasertib in Cancer PatientsCompletedNo Results AvailableNeoplasmsDrug: Pimasertib Capsule (Part A)|Drug: Pimasertib Tablet (Part A)|Drug: Pimasertib Tablet (Part A)|Drug: Pimasertib Capsule (Part A)|Drug: Pimasertib Capsule (Part B and trial extension phase)https://ClinicalTrials.gov/show/NCT01992874
4375843758MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical CancerRecruitingNo Results AvailableCervical Adenocarcinoma|Cervical Adenosquamous Carcinoma|Cervical Squamous Cell Carcinoma|Cervical Undifferentiated Carcinoma|Recurrent Cervical Carcinoma|Stage IB Cervical Cancer|Stage IIA Cervical Cancer|Stage IIB Cervical Cancer|Stage IIIA Cervical CanProcedure: Computed Tomography|Procedure: Diffusion Weighted Imaging|Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging|Radiation: Fludeoxyglucose F-18|Procedure: Magnetic Resonance Spectroscopic Imaging|Procedure: Positron Emission Tomographyhttps://ClinicalTrials.gov/show/NCT01992861
4375943759MAP-Calcification: MicroRNAs as Potential Biomarkers for Coronary Artery CalcificationRecruitingNo Results AvailableCoronary Artery Calcification|Coronary Artery Disease|Osteoporosis|OsteopeniaOther: Venous blood sampling|Other: 4-day food diary|Other: 1 week UV dosimeter|Radiation: Peripheral Quantitative Computed Tomography of the radiushttps://ClinicalTrials.gov/show/NCT01992848
4376043760Resolution of Allergic InflammationNot yet recruitingNo Results AvailableGrass Pollen Allergic RhinitisOther: Grass pollen allergen extract|Other: placebohttps://ClinicalTrials.gov/show/NCT01992835
4376143761Pain Sensitivity of Subjects With Fibromyalgia Before and After Repetitive Transcranial Magnetic Stimulation TreatmentRecruitingNo Results AvailableFibromyalgiaOther: experimental pain inductionhttps://ClinicalTrials.gov/show/NCT01992822
4376243762Omega 3 Supplementation in Fatty LiverCompletedNo Results AvailableFatty LiverDietary Supplement: Omega 3https://ClinicalTrials.gov/show/NCT01992809
4376343763Angiotensin II Antagonist in Severe SepsisNot yet recruitingNo Results AvailableSevere SepsisDrug: Irbesartanhttps://ClinicalTrials.gov/show/NCT01992796
4376443764Resistant Starch, Antioxidant Status and Insulin ResistanceCompletedNo Results AvailableOverweight|ObesityDietary Supplement: Hi-maize resistant starch|Dietary Supplement: Maltodextrinhttps://ClinicalTrials.gov/show/NCT01992783
4376543765A Stepped-care Model of Tailored Behavioural Medicine Pain Intervention in Primary CareNot yet recruitingNo Results AvailableMusculoskeletal PainBehavioral: Hierarchical graded exposure|Behavioral: Graded activity|Behavioral: Physical exerciseshttps://ClinicalTrials.gov/show/NCT01992770
4376643766Thromboelastography-derived Functional Fibrinogen LevelsRecruitingNo Results AvailableFocus of Study|Coagulation Status of Cardiac Surgery Patient|Reducing Excess Blood Transfusionhttps://ClinicalTrials.gov/show/NCT01992757
4376743767BDNF Pregnancy StudyCompletedNo Results AvailablePregnancyhttps://ClinicalTrials.gov/show/NCT01992744
4376843768IUI vs. IVF/ICSI in Women Aged 38-42 Years: a Prospective Randomized Controlled Trial.RecruitingNo Results AvailableInfertilityOther: Drug: Follitropine Bètahttps://ClinicalTrials.gov/show/NCT01992731
4376943769What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound ElastographyRecruitingNo Results AvailableUterine Bleeding|Uterine Fibroids|AdenomyosisProcedure: ARM 1: Evaluation of MRI, US for pelvic and uterine conditions|Procedure: ARM 2 Patient preference between MRI and Ultrasoundhttps://ClinicalTrials.gov/show/NCT01992718
4377043770Borderline Pancreas Study: FOLFIRINOX +SBRTRecruitingNo Results AvailableResectable Pancreatic CancerOther: Chemotherapy(FOLFIRINOX) + SBRT prior to surgery if applicable|Drug: -Oxaliplatin 85 mg/m2 IV on Day 1|Drug: -Irinotecan 180 mg/m2 IV on Day 1|Drug: -5-FU (Fluorouracil) 2,400 mg/m2 IV over 46-48 hourshttps://ClinicalTrials.gov/show/NCT01992705

* Görseller ve İçerik tekif hakkına sahip olabilir